| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |